Diabetes Mellitus, Type 2: all 9,589 studies

Page 90 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.

• Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose MonitoringCompletedNCT00542698Phase 1
• An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT00542633Phase 3
• Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes MellitusCompletedNCT00541983Phase 1
• Obesity and Diabetes Prevention Through Science EnrichmentCompletedNCT00541879Not applicable
• Eze/Simva Switch Study in Diabetics (0653A-807)CompletedNCT00541697Phase 3
• Pharmacist Assisted Medication Program Enhancing the Regulation of DiabetesCompletedNCT00541606Not applicable
• BMS-646256 in Obese and Overweight Type 2 DiabeticsWithdrawnNCT00541567Phase 2/3
• Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination TabletCompletedNCT00541437
• Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional FormulasCompletedNCT00540488Phase 3
• Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes MellitusStatus unknownNCT00540462Phase 4
• Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT00539890Phase 3
• Phase I Multiple-Ascending Dose (Japan)CompletedNCT00538174Phase 1
• Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.CompletedNCT00537719Phase 1
• Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 DiabetesCompletedNCT00536549Not applicable
• Vitamin C and Cardiovascular RiskCompletedNCT00534014Not applicable
• The Effect of Patients' Participation in Improving Diabetes CareCompletedNCT00533494Phase 3
• A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy AdultsCompletedNCT00532610Phase 1
• Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes MellitusCompletedNCT00532506Phase 2
• Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes MellitusCompletedNCT00530881Phase 2
• Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusCompletedNCT00530309Phase 1
• Continuous Glucose Monitoring in Patients With Type 2 DiabetesStatus unknownNCT00529815Phase 4
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human InsulinCompletedNCT00529165Not applicable
• Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 DiabetesCompletedNCT00529048
• Comparison of Apidra to Regular Insulin in Hospitalized PatientsCompletedNCT00528918Not applicable
• Acute Effects of Sildenafil on Endothelial Function in People With DiabetesCompletedNCT00527995Phase 3
• Telemedicine Influence in the Follow up of the Type 2 Diabetes PatientCompletedNCT00527254Not applicable
• A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin AloneCompletedNCT00525330Phase 2
• A Study Of BRL49653C For The Treatment Of Type 2 DiabetesCompletedNCT00523913Phase 3
• Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor CellsStatus unknownNCT00523393Phase 4
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
• Effects of Rosiglitazone on Serum Ghrelin and Peptide YY LevelsCompletedNCT00522470Phase 4
• Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and CognitionCompletedNCT00522158Phase 4
• The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
• A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT00521378
• Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High RiskCompletedNCT00520962
• Dietary Interventions in Type 2 Obese Diabetic Patients in the CommunityStatus unknownNCT00520182Phase 3
• Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00520065Phase 2
• Safety Study of ISIS 325568 in Healthy VolunteersCompletedNCT00519727Phase 1
• A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of MetforminCompletedNCT00519480Phase 1
• Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusCompletedNCT00519142Phase 3
• Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline GlargineCompletedNCT00518427Phase 4
• The Finnish Diabetes Prevention StudyActive, not recruitingNCT00518167Not applicable
• A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00517465Phase 1
• A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 DiabetesCompletedNCT00517283Phase 1
• Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin TherapyCompletedNCT00515632Phase 3
• Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNCT00513630Phase 4
• Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes MellitusCompletedNCT00513214Phase 1/2
• 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 DiabetesCompletedNCT00511732Phase 2
• Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 DiabetesCompletedNCT00511719Phase 2
• Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 DiabetesCompletedNCT00511602Phase 2
• The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 DiabeticsCompletedNCT00508599Not applicable
• Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 DiabetesCompletedNCT00508287Phase 1
• Study of CRx-401 on Glucose Levels in Subjects With Type II DiabetesCompletedNCT00506298Phase 2
• Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic ControlCompletedNCT00506194Not applicable
• A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female VolunteersCompletedNCT00504816Phase 1
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
• A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.CompletedNCT00502710Phase 2
• A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy VolunteersCompletedNCT00501930Phase 1
• A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male VolunteersCompletedNCT00501683Phase 1
• A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney FunctionCompletedNCT00501462Phase 1
• A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy VolunteersCompletedNCT00501397Phase 1
• Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
• Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
• GIANT: General Practitioner Implementation in Asia of Normoglycaemic TargetsCompletedNCT00499824Not applicable
• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
• Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 DiabetesCompletedNCT00499148Phase 2/3
• Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 DiabetesCompletedNCT00497133
• Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight SubjectsCompletedNCT00495014Phase 1
• Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
• Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT00494884Phase 3
• Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active DrugsCompletedNCT00494767Phase 1
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 DiabetesTerminatedNCT00494663Phase 2
• Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 DiabetesCompletedNCT00490867Phase 2
• A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
• DOMME Dose Optimization Multicentric Mexican EvaluationCompletedNCT00488527Phase 4
• Impact of Diet and Exercise Activity on Pregnancy OutcomesActive, not recruitingNCT00486629Not applicable
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL StudyCompletedNCT00486187Not applicable
• A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes MellitusStatus unknownNCT00482950Phase 2
• Comparison Between Pioglitazone and SES With type2 DMCompletedNCT00482183Phase 2/3
• A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)CompletedNCT00482079Phase 2
• Worksite Nutrition StudyCompletedNCT00481897Not applicable
• A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)CompletedNCT00481663Phase 2
• Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot StudyWithdrawnNCT00481429
• Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 DiabetesCompletedNCT00481117Phase 1
• HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)CompletedNCT00480805Phase 3
• Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart DiseaseCompletedNCT00479986Phase 4
• The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia BarkStatus unknownNCT00479973Phase 2
• Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty AcidsCompletedNCT00479791Not applicable
• Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseTerminatedNCT00478972Phase 3
• Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugTerminatedNCT00478595Phase 3
• Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic SubjectsCompletedNCT00478322Phase 2
• A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCompletedNCT00477581Phase 4
• Clinical Trial of SB-509 in Subjects With Diabetic NeuropathyCompletedNCT00476931Phase 2
• Effects of Colesevelam HCl On Bile Acid KineticsCompletedNCT00476710
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult MalesCompletedNCT00475371Phase 1
• Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin TherapyCompletedNCT00474838Phase 4
• Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2Status unknownNCT00473733Phase 4

← Diabetes Mellitus, Type 2 overview